Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-05-08 | Dr. Vincent, age 66, has been a Professor of Oncology... Dr. Vincent makes valuable contributions to the Board based on over 25 years of experience as a medical oncologist... The current members of the Corporate Governance and Nominating Committee are Mark Vincent, Carol Ashe and Caroline Loewy... The following table details the compensation received by each director for the year ended December 31, 2018: Dr. Mark Vincent 52,000 fees earned or paid in cash, 121,713 option awards, total 173,713. |
| 2020-04-24 | Dr. Vincent, age 67, has been a Professor of Oncology... Dr. Vincent makes valuable contributions to the Board based on over 25 years of experience as a medical oncologist... The current members of the Corporate Governance and Nominating Committee are Mark Vincent, Carol Ashe and Caroline Loewy... The following table details the compensation received by each non-employee director for the year ended December 31, 2019: Dr. Mark Vincent 52,000 Fees earned or paid in cash, 51,630 Option awards, Total 103,630. |
| 2021-04-21 | Dr. Vincent, age 68, has been a Professor of Oncology at the University of Western Ontario since 2008... Dr. Vincent received this amount for his services as director on the Board and as Chair of the Board’s Corporate Governance and Nominating Committee. |
| 2022-04-20 | Dr. Vincent, age 69, has been a Professor of Oncology at the University of Western Ontario since 2008... Dr. Vincent received this amount for his services as director on the Board and as Chair of the Board’s Corporate Governance and Nominating Committee. |
| 2023-04-19 | Dr. Vincent earned this amount for his services as director on the Board and as Chair of the Board’s Corporate Governance and Nominating Committee. |
| 2024-05-15 | Dr. Vincent, age 71, has been a Professor of Oncology... He is Chair of the Corporate Governance and Nominating Committee and member of the R&D Committee... Dr. Vincent earned $85,000 for his services as director on the Board, Chair of the Corporate Governance and Nominating Committee and member of the R&D Committee. Total compensation $127,682. |
Data sourced from SEC filings. Last updated: 2026-02-03